Enjoy complimentary customisation on priority with our Enterprise License!
The bone biopsy market is estimated to grow at a CAGR of 7.74% between 2022 and 2027. The size of the market is forecast to increase by USD 76.77 million. The growth of the market depends on several factors, including the growing number of diagnostic centers, the rising prevalence of cancer, and the increasing preference for minimally invasive biopsies.
This report extensively covers market segmentation by type (needle biopsy and open biopsy), end-user (hospitals and diagnostic centers), and geography (North America, Europe, Asia, and Rest Of World (ROW)). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
To learn more about this report, Download Report Sample
The reports categorize the global bone biopsy market as a part of the global healthcare equipment market. The parent global healthcare equipment market covers products and companies engaged in research and development (R&D) of a variety of product categories, including capital equipment, instruments, implants, accessories, and consumables that are used for the diagnosis, monitoring, and treatment of various diseases. Our research report has extensively covered external factors influencing the parent market growth during the forecast period.
The rising prevalence of cancer is notably driving the market growth, although factors such as the risk of infections associated with the use of biopsy needles may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Bone Biopsy Market Driver
The rising prevalence of cancer is notably driving market growth. Cancer is becoming a major health concern as it is one of the most common chronic diseases worldwide and is responsible for rising mortality rates for people worldwide. Bone cancer is one of the most common types of cancer.
Approximately 70% of cancer patients are suitable for biopsy. End-users are increasingly preferring needle biopsy over open biopsy, as it is non-invasive and can detect the presence of various cancers more effectively using the individual blood sample. It provides vital information to the oncologist to select the appropriate treatment methods, including the type of surgery, radiotherapy, and drugs required for the treatment. Thus, the increasing incidence of cancers will subsequently increase the diagnosis using the biopsy method, which is expected to drive the growth of the market during the forecast period.
Significant Bone Biopsy Market Trend
The growing demand for MRI and ultrasound-guided bone biopsy procedures is the key trend in the market. MRI has witnessed a rapid improvement in the management of bone cancer in the last decade. In addition, the MRI technique can provide functional information through magnetic resonance spectroscopy, dynamic contrast-enhanced (DCE), and diffusion-weighted imaging (DWI). The multi-parametric features of MRI have the potential to exclude significant cancer in most cases. Performing an MRI before a bone biopsy reduces the invasiveness of the treatment procedure by limiting the number of cores needed to make an accurate diagnosis.
Evolving techniques in ultrasound, such as contrast-enhanced ultrasound (CEUS) and real-time ultrasound elastography (RTE), are being tested to improve and detect the yield by allowing targeted biopsies. Therefore, the rise in demand for bone cancer screening with /image guidance is estimated to propel the growth of the market during the forecast market.
Major Bone Biopsy Market Challenge
The risk of infections associated with the use of biopsy needles is the major challenge impeding the market growth. In several reported cases, bone needle biopsies have been known to cause significant complications among patients such as bleeding, infection, pain, fever, and transient urinary problems. In a few cases, individuals would also require hospitalization due to these complications. In addition, faulty execution of biopsies can cause damage to nearby tissues or organs, as well as skin numbness around the biopsy site. A range of complications that can occur after a bone needle biopsy include bacteremia accompanied by sepsis, asymptomatic bacteriuria, and urinary tract infection.
According to multiple research studies, the risk of post-biopsy infection for a man who has undergone more than two previous biopsies is about 2%, and then rises correspondingly to 5%, 10%, and 15% in individuals who underwent bone biopsies three, four, or more than four biopsies, respectively. Thus, there is a growing need among the end-users the adoption of liquid biopsy tests, owing to complications associated with needle biopsies. Therefore it is expected to obstruct the growth of the market during the forecast period.
Key Bone Biopsy Market Customer Landscape
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Bone Biopsy Market Customer Landscape
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Tsunami Medical Srl - The company operates under one segment. The company offers bone biopsy kits with a coaxial design as its key offering which allows biopsy collection of the core sample within the vertebral body. Under this segment, the company is one of the leaders in spine technology innovation which focus on 3D printed solutions for spine surgery and diagnostic invasive procedures.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
The market share growth of the needle biopsy segment will be significant during the forecast period. Needle biopsies are majorly performed as minimally invasive biopsy procedures for the better assessment of bone cancer within an outpatient setting. The need for highly skilled operators to handle imaging modalities such as CT scans and the lower technical complexities involved in this method are driving the demand for bone biopsy needles for the extraction of normal bone tissues for biopsy.
Get a glance at the market contribution of various segments Request a PDF Sample
The needle biopsy segment was valued at USD 85.44 million in 2017 and continued to grow until 2021. Core needle biopsy (CNB) and fine-needle aspiration biopsy (FNAB) are the two major types of needle biopsies that are performed in the presence of a palpable mass or a non-palpable abnormal finding. A needle biopsy is considered the gold standard procedure for bone biopsies. Core needle biopsy is a quick process for bone biopsy, as it does not involve surgery. Owing to these factors, needle bone biopsies are accepted by physicians as standard biopsy procedures.
For more insights on the market share of various regions Request PDF Sample now!
North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The bone biopsy market in North America will grow at a moderate rate during the forecast period. North America has been witnessing an increase in the adoption of various advanced technologies over the past few years. The majority of the market growth in this region is driven by high technology adoption in the healthcare sector, increasing healthcare expenditure, and the rising prevalence of bone cancer. In addition, the growing presence of vendors that manufacture bone biopsy systems and increasing technological advances in biopsy techniques are driving the growth of the market in North America.
In North America, the COVID-19 pandemic had a devastating impact on the US. The outbreak had a negative impact on the growth of the regional market in 2020-2021, as it led to a decline in the treatment and diagnosis of bone cancer in the region due to the postponements, delays, and halt of bone cancer therapies, as the focus was more on treating the COVID patients. This impeded the growth of the regional market. However, patients have currently started visiting hospitals for the diagnosis of bone cancer and for related surgical procedures that are carried out with all the necessary measures and precautions. This has increased the usage of bone biopsy systems in the region. Therefore, it is expected to enhance the growth of the regional market during the forecast period.
The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
|
Bone Biopsy Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
155 |
|
Base year |
2022 |
|
Historic period |
2017-2021 |
|
Forecast period |
2023-2027 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 7.74% |
|
Market growth 2023-2027 |
USD 76.77 million |
|
Market structure |
Fragmented |
|
YoY growth 2022-2023(%) |
6.92 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 38% |
|
Key countries |
US, Germany, France, China, and Japan |
|
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Becton Dickinson and Co., BIOPSYBELL Srl, Cardinal Health Inc., Cook Group Inc., Kimal Group, Laurane Medical LLC, Meditech Devices Pvt. Ltd., Medtronic Plc, Merit Medical Systems Inc., Moller Medical GmbH, Remington Medical, SOMATEX Medical Technologies GmbH, Teleflex Inc., Tsunami Medical Srl, Zamar Care, B. Braun SE, and Stryker Corp. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
Let us help you make report more suited to your requirements.
Get the report (PDF) sent to your email within minutes.
